Product Information

DILTIAZEM 24H ER(CD) 360 MG CP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3532 per EA under NDC 50742025230. Its NADAC has been published 276 times since May 12, 2021.

FDA first approved this application on Jun 14, 2019. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 24H ER(CD) 360 MG CP

diltiazem hydrochloride
$0.3532per EA

Strength

360 mg/1

NDC

50742025230

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208783

FDA Approved

6/14/2019

TE Code

AB3

On Market Since

6/14/2019

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has been published 276 times since May 12, 2021, and over the history we have for it it has declined 89.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3532 per EA
All-time high$4.0433 (Aug 11, 2021)
All-time low$0.1898 (Jul 17, 2024)
52-week high$0.3601
52-week low$0.3270
Median price$0.3502
Average price$0.8331
Largest weekly change+73.9% (Aug 21, 2024)
Weeks tracked276
Tracking sinceMay 12, 2021

Price History

1W

-1.2%

1M

+0.8%

3M

+0.1%

6M

+0.1%

1Y

+6.9%

3Y

+21.4%

5Y

-85.5%

All

-89.2%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 24H ER(CD) 360 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 360 MG CP, manufactured by Ingenus Pharmaceuticals LLC, is $0.3532 per EA (NDC 50742025230), effective Aug 19, 2026.

How has the price of DILTIAZEM 24H ER(CD) 360 MG CP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has declined 89.2%. It has been tracked across 276 weekly CMS publications since May 12, 2021.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 360 MG CP?

Since May 12, 2021, the NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has ranged from a low of $0.1898 (Jul 17, 2024) to a high of $4.0433 (Aug 11, 2021), with a median of $0.3502 per EA.

Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 360 MG CP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIADYLT ER 360 MG CAPSULE, is $0.3259 per EA — about 8% below DILTIAZEM 24H ER(CD) 360 MG CP.

Who manufactures DILTIAZEM 24H ER(CD) 360 MG CP?

DILTIAZEM 24H ER(CD) 360 MG CP (NDC 50742025230) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.